26
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Polymer-Based Nanomaterials and Applications for Vaccines and Drugs

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Nanotechnology plays a significant role in drug development. As carriers, polymeric nanoparticles can deliver vaccine antigens, proteins, and drugs to the desired site of action. Polymeric nanoparticles with lower cytotoxicity can protect the delivered antigens or drugs from degradation under unfavorable conditions via a mucosal administration route; further, the uptake of nanoparticles by antigen-presenting cells can increase and induce potent immune responses. Additionally, nanomaterials are widely used in vaccine delivery systems because nanomaterials can make the vaccine antigen long-acting. This review focuses on some biodegradable polymer materials such as natural polymeric nanomaterials, chemically synthesized polymer materials, and biosynthesized polymeric materials, and points out the advantages and the direction of research on degradable polymeric materials. The application and future perspectives of polymeric materials as delivery carriers and vaccine adjuvants in the field of drugs and vaccines are presented. With the increase of knowledge and fundamental understandings of polymer-based nanomaterials, means of integrating some other attractive properties, such as slow release, target delivery, and alternative administration methods and delivery pathways are feasible. Polymer-based nanomaterials have great potential for the development of novel vaccines and drug systems for certain needs, including single-dose and needle-free deliveries of vaccine antigens and drugs in the future.

          Related collections

          Most cited references67

          • Record: found
          • Abstract: not found
          • Article: not found

          A review of chitin and chitosan applications

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            "Nanoantibiotics": a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era.

            Despite the fact that we live in an era of advanced and innovative technologies for elucidating underlying mechanisms of diseases and molecularly designing new drugs, infectious diseases continue to be one of the greatest health challenges worldwide. The main drawbacks for conventional antimicrobial agents are the development of multiple drug resistance and adverse side effects. Drug resistance enforces high dose administration of antibiotics, often generating intolerable toxicity, development of new antibiotics, and requests for significant economic, labor, and time investments. Recently, nontraditional antibiotic agents have been of tremendous interest in overcoming resistance that is developed by several pathogenic microorganisms against most of the commonly used antibiotics. Especially, several classes of antimicrobial nanoparticles (NPs) and nanosized carriers for antibiotics delivery have proven their effectiveness for treating infectious diseases, including antibiotics resistant ones, in vitro as well as in animal models. This review summarizes emerging efforts in combating against infectious diseases, particularly using antimicrobial NPs and antibiotics delivery systems as new tools to tackle the current challenges in treating infectious diseases. Copyright © 2011 Elsevier B.V. All rights reserved.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Antibacterial action of chitosan and carboxymethylated chitosan

                Bookmark

                Author and article information

                Journal
                Polymers (Basel)
                Polymers (Basel)
                polymers
                Polymers
                MDPI
                2073-4360
                02 January 2018
                January 2018
                : 10
                : 1
                : 31
                Affiliations
                [1 ]Key Laboratory of Chemical Engineering Process and Technology for High-efficiency Conversion, College of Chemistry and Material Sciences, Heilongjiang University, Harbin 150080, China; hanjinyu1018@ 123456126.com
                [2 ]Key Laboratory of Microbiology, School of Life Science, Heilongjiang University, Harbin 150080, China; zhaodandan@ 123456hlju.edu.cn (D.Z.); docor1005@ 123456163.com (D.L.); zybin395@ 123456163.com (X.W.)
                [3 ]School of Biological Science and Technology, University of Jinan, Jinan 250022, China
                Author notes
                [* ]Correspondence: jinzheng@ 123456hlju.edu.cn (Z.J.); zhaokai@ 123456hlju.edu.cn (K.Z.); Tel.: +86-451-8660-8131 (Z.J.); +86-451-8660-8586 (K.Z.); Fax: +86-451-8660-8131 (Z.J.); +86-451-8660-9016 (K.Z.)
                [†]

                These authors contributed equally to this study.

                Article
                polymers-10-00031
                10.3390/polym10010031
                6415012
                30966075
                e81f39f4-bbaf-469b-8937-c9f1423bb4ae
                © 2018 by the authors.

                Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ( http://creativecommons.org/licenses/by/4.0/).

                History
                : 09 October 2017
                : 21 December 2017
                Categories
                Review

                vaccines,drugs,polymer-based nanomaterials,nanoparticles,delivery carriers,vaccine adjuvants

                Comments

                Comment on this article